Ingestion of low dose pyroglutamyl leucine improves dextran sulfate sodium-induced colitis and intestinal microbiota in mice

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 37, 2013, Pages 8807-8813

  Wada, Sayori ^a   Sato, Kenji ^a   Ohta, Ryoko ^a   Wada, Eri ^a   Bou, Yukiho ^a   Fujiwara, Miki ^a   Kiyono, Tamami ^a   Park, Eun Young ^a   Aoi, Wataru ^a   Takagi, Tomohisa ^b   Naito, Yuji ^b   Yoshikawa, Toshikazu ^b  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

colitis; gluten peptide; IBD; microbiota; pyroGlu Leu

Indexed keywords

COLITIS; GLUTEN PEPTIDES; IBD; MICROBIOTAS; PYROGLU-LEU;

AMINO ACIDS; PEPTIDES; SODIUM;

DISEASES;

ANTIINFLAMMATORY AGENT; DEXTRAN SULFATE; DIPEPTIDE; DRUG DERIVATIVE; PYROGLUTAMIC ACID; PYROGLUTAMYLLEUCINE;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COLITIS; DISEASE MODEL; DRUG EFFECT; HUMAN; INTESTINE; MALE; MICROBIOLOGY; MICROFLORA; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; COLITIS; DEXTRAN SULFATE; DIPEPTIDES; DISEASE MODELS, ANIMAL; HUMANS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; MICROBIOTA; PYRROLIDONECARBOXYLIC ACID;

EID: 84884497327     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf402515a     Document Type: Article

References (39)

1. Xavier, R. J.; Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease Nature 2007, 448, 427-434
2. Podolsky, D. K. Inflammatory bowel disease N. Engl. J. Med. 2002, 347, 417-429
3. Australian Crohn's and Colitis Association (ACCA). The economic costs of Crohn's disease andulcerative colitis. https://www.crohnsandcolitis.com.au/ content/Deloitte-Access-Economics-Report.pdf (accessed June 6, 2013).
4. Kappelman, M. D.; Rifas-Shiman, S. L.; Porter, C. Q.; Ollendorf, D. A.; Sandler, R. S.; Galanko, J. A.; Finkelstein, J. A. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults Gastroenterology 2008, 135, 1907-1913
5. Andersson, R. E.; Olaison, G.; Tysk, C.; Ekbom, A. Appendectomy and protection against ulcerative colitis N. Engl. J. Med. 2001, 344, 808-814
6. Evans, J. M.; McMahon, A. D.; Murray, F. E.; McDevitt, D. G.; MacDonald, T. M. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease Gut 1997, 40, 619-622
7. Cosnes, J.; Beaugerie, L.; Carbonnel, F.; Gendre, J. P. Smoking cessation and the course of Crohn's disease: An intervention study Gastroenterology 2001, 120, 1093-1099
8. Lindberg, E.; Tysk, C.; Andersson, K.; Jarnerot, G. Smoking and inflammatory bowel disease. A case control study Gut 1988, 29, 352-357
9. Mahid, S. S.; Minor, K. S.; Soto, R. E.; Hornung, C. A.; Galandiuk, S. Smoking and inflammatory bowel disease: A meta-analysis Mayo Clin. Proc. 2006, 81, 1462-1471
10. Yoshida, Y.; Murata, Y. Inflammatory bowel disease in Japan: Studies of epidemiology and etiopathogenesis Med. Clin. North Am. 1990, 74, 67-90
11. Shoda, R.; Matsueda, K.; Yamato, S.; Umeda, N. Epidemiologic analysis of Crohn disease in Japan: Increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan Am. J. Clin. Nutr. 1996, 63, 741-745
12. Thia, K. T.; Loftus, E. V., Jr.; Sandborn, W. J.; Yang, S. K. An update on the epidemiology of inflammatory bowel disease in Asia Am. J. Gastroenterol. 2008, 103, 3167-3182
13. Food Security Division, Minister's Secretariat. Food balance sheet. http://www.e-stat.go.jp/SG1/estat/List.do?lid=000001108413 (accessed June 6, 2013).
14. Sakamoto, N.; Kono, S.; Wakai, K.; Fukuda, Y.; Satomi, M.; Shimoyama, T.; Inaba, Y.; Miyake, Y.; Sasaki, S.; Okamoto, K.; Kobashi, G.; Washio, M.; Yokoyama, T.; Date, C.; Tanaka, H. Dietary risk factors for inflammatory bowel disease: A multicenter case-control study in Japan Inflamm. Bowel. Dis. 2005, 11, 154-163
15. Katayama, S.; Mine, Y. Antioxidative activity of amino acids on tissue oxidative stress in human intestinal epithelial cell model J. Agric. Food Chem. 2007, 55, 8458-8464
16. Sprong, R. C.; Schonewille, A. J.; van der Meer, R. Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: Role of mucin and microbiota J. Dairy Sci. 2010, 93, 1364-1371
17. Daddaoua, A.; Puerta, V.; Zarzuelo, A.; Suarez, M. D.; Sanchez de Medina, F.; Martinez-Augustin, O. Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis J. Nutr. 2005, 135, 1164-1170
18. Lee, M.; Kovacs-Nolan, J.; Yang, C.; Archbold, T.; Fan, M. Z.; Mine, Y. Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis J. Agric. Food Chem. 2009, 57, 2233-2240
19. Kovacs-Nolan, J.; Zhang, H.; Ibuki, M.; Nakamori, T.; Yoshiura, K.; Turner, P. V.; Matsui, T.; Mine, Y. The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation Biochim. Biophys. Acta 2012, 1820, 1753-1763
20. Akobeng, A. K.; Miller, V.; Stanton, J.; Elbadri, A. M.; Thomas, A. G. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease J. Pediatr. Gastroenterol. Nutr. 2000, 30, 78-84
21. Suzuki, Y.; Asano, M.; Sato, K.; Asami, M.; Sakamoto, A.; Tsutsumi, M.; Kido, Y. Wheat gluten hydrolysate alters the progress of hepatic pathology induced by prolonged carbon tetrachloride administration in rat Biomed. Res. 2012, 22, 481-488
22. Sato, K.; Egashira, Y.; Shin Ono, S.; Satoshi Mochizuki, S.; Shimmura, Y.; Suzuki, Y.; Nagata, M.; Hashimoto, K.; Kiyono, T.; Park, E. Y.; Nakamura, Y.; Itabashi, M.; Sakata, Y.; Furuta, S.; Sanada, H. Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine-induced acute hepatitis in rat J. Agric. Food Chem. 2013, 61, 6304-6310
23. Horiguchi, N.; Horiguchi, H.; Suzuki, Y. Out-hospital patients with hyperlipidemia and hepatitis with various backgrounds improved by wheat protein hydrolysate (glutamine peptide) administration Jpn. Pharmacol. Ther. 2004, 32, 415-420
24. Higaki-Sato, N.; Sato, K.; Esumi, Y.; Okumura, T.; Yoshikawa, H.; Tanaka-Kuwajima, C.; Kurata, A.; Kotaru, M.; Kawabata, M.; Nakamura, Y.; Ohtsuki, K. Isolation and identification of indigestible pyroglutamyl peptides in an enzymatic hydrolysate of wheat gluten prepared on an industrial scale J. Agric. Food Chem. 2003, 51, 8-13
25. Takagi, T.; Naito, Y.; Uchiyama, K.; Suzuki, T.; Hirata, I.; Mizushima, K.; Tsuboi, H.; Hayashi, N.; Handa, O.; Ishikawa, T.; Yagi, N.; Kokura, S.; Ichikawa, H.; Yoshikawa, T. Carbon monoxide liberated from carbon monoxide-releasing molecule exerts an anti-inflammatory effect on dextran sulfate sodium-induced colitis in mice Dig. Dis. Sci. 2011, 56, 1663-1671
26. Naito, Y.; Katada, K.; Takagi, T.; Tsuboi, H.; Isozaki, Y.; Handa, O.; Kokura, S.; Yoshida, N.; Ichikawa, H.; Yoshikawa, T. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice Int. J. Mol. Med. 2006, 17, 997-1004
27. Murano, M.; Maemura, K.; Hirata, I.; Toshina, K.; Nishikawa, T.; Hamamoto, N.; Sasaki, S.; Saitoh, O.; Katsu, K. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis Clin. Exp. Immunol. 2000, 120, 51-58
28. Endo, A.; Okada, S.; Morita, H. Molecular profiling of Lactobacillus, Streptococcus, and Bifidobacterium species in feces of active racehorses J. Gen. Appl. Microbiol. 2007, 53, 191-200
29. Matsuki, T.; Watanabe, K.; Fujimoto, J.; Miyamoto, Y.; Takada, T.; Matsumoto, K.; Oyaizu, H.; Tanaka, R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces Appl. Environ. Microbiol. 2002, 68, 5445-5451
30. Matsuki, T.; Watanabe, K.; Fujimoto, J.; Takada, T.; Tanaka, R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces Appl. Environ. Microbiol. 2004, 70, 7220-7228
31. Sartor, R. B. Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3, 390-407
32. Frank, D. N.; St Amand, A. L.; Feldman, R. A.; Boedeker, E. C.; Harpaz, N.; Pace, N. R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 13780-13785
33. Sokol, H.; Seksik, P.; Furet, J. P.; Firmesse, O.; Nion-Larmurier, I.; Beaugerie, L.; Cosnes, J.; Corthier, G.; Marteau, P.; Dore, J. Low counts of Faecalibacterium prausnitzii in colitis microbiota Inflammatory Bowel Dis. 2009, 15, 1183-1189
34. Ricanek, P.; Lothe, S. M.; Frye, S. A.; Rydning, A.; Vatn, M. H.; Tonjum, T. Gut bacterial profile in patients newly diagnosed with treatment-naive Crohn's disease Clin. Exp. Gastroenterol. 2012, 5, 173-186
35. Wehkamp, J.; Salzman, N. H.; Porter, E.; Nuding, S.; Weichenthal, M.; Petras, R. E.; Shen, B.; Schaeffeler, E.; Schwab, M.; Linzmeier, R.; Feathers, R. W.; Chu, H.; Lima, H., Jr.; Fellermann, K.; Ganz, T.; Stange, E. F.; Bevins, C. L. Reduced Paneth cell alpha-defensins in ileal Crohn's disease Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 18129-18134
36. Masuda, K.; Sakai, N.; Nakamura, K.; Yoshioka, S.; Ayabe, T. Bactericidal activity of mouse alpha-defensin cryptdin-4 predominantly affects noncommensal bacteria J. Innate Immun. 2011, 3, 315-326
37. Faure, M.; Mettraux, C.; Moennoz, D.; Godin, J. P.; Vuichoud, J.; Rochat, F.; Breuille, D.; Obled, C.; Corthesy-Theulaz, I. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats J. Nutr. 2006, 136, 1558-1564
38. Ouyang, N.; Zhu, C.; Zhou, D.; Nie, T.; Go, M. F.; Richards, R. J.; Rigas, B. MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis PLoS One 2012, 7, e41585
39. Bettenworth, D.; Buyse, M.; Bohm, M.; Mennigen, R.; Czorniak, I.; Kannengiesser, K.; Brzoska, T.; Luger, T. A.; Kucharzik, T.; Domschke, W.; Maaser, C.; Lugering, A. The tripeptide KdPT protects from intestinal inflammation and maintains intestinal barrier function Am. J. Pathol. 2011, 179, 1230-1242